Ardelyx Stock Performance
| ARDX Stock | USD 7.74 0.05 0.64% |
On a scale of 0 to 100, Ardelyx holds a performance score of 9. The firm shows a Beta (market volatility) of 0.77, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Ardelyx's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ardelyx is expected to be smaller as well. Please check Ardelyx's standard deviation, expected short fall, relative strength index, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Ardelyx's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Ardelyx are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Ardelyx showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 21.5 M | |
| Total Cashflows From Investing Activities | -18.3 M |
Ardelyx Relative Risk vs. Return Landscape
If you would invest 595.00 in Ardelyx on November 5, 2025 and sell it today you would earn a total of 179.00 from holding Ardelyx or generate 30.08% return on investment over 90 days. Ardelyx is currently generating 0.5298% in daily expected returns and assumes 4.5801% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than Ardelyx, and 90% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Ardelyx Target Price Odds to finish over Current Price
The tendency of Ardelyx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 7.74 | 90 days | 7.74 | nearly 4.66 |
Based on a normal probability distribution, the odds of Ardelyx to move above the current price in 90 days from now is nearly 4.66 (This Ardelyx probability density function shows the probability of Ardelyx Stock to fall within a particular range of prices over 90 days) .
Ardelyx Price Density |
| Price |
Predictive Modules for Ardelyx
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ardelyx. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ardelyx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ardelyx Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ardelyx is not an exception. The market had few large corrections towards the Ardelyx's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ardelyx, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ardelyx within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.49 | |
β | Beta against Dow Jones | 0.77 | |
σ | Overall volatility | 0.84 | |
Ir | Information ratio | 0.10 |
Ardelyx Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ardelyx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ardelyx can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ardelyx appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 333.62 M. Net Loss for the year was (39.14 M) with profit before overhead, payroll, taxes, and interest of 288.94 M. | |
| Ardelyx currently holds about 90.62 M in cash with (44.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Roughly 70.0% of the company shares are held by institutions such as insurance companies |
Ardelyx Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ardelyx Stock often depends not only on the future outlook of the current and potential Ardelyx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ardelyx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 235.2 M | |
| Cash And Short Term Investments | 250.1 M |
Ardelyx Fundamentals Growth
Ardelyx Stock prices reflect investors' perceptions of the future prospects and financial health of Ardelyx, and Ardelyx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ardelyx Stock performance.
| Return On Equity | -0.36 | |||
| Return On Asset | -0.0555 | |||
| Profit Margin | (0.14) % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 1.87 B | |||
| Shares Outstanding | 242.97 M | |||
| Price To Earning | (2.11) X | |||
| Price To Book | 12.13 X | |||
| Price To Sales | 4.69 X | |||
| Revenue | 333.62 M | |||
| EBITDA | (16.71 M) | |||
| Cash And Equivalents | 90.62 M | |||
| Cash Per Share | 0.48 X | |||
| Total Debt | 153.44 M | |||
| Debt To Equity | 0.56 % | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | (44.81 M) | |||
| Earnings Per Share | (0.23) X | |||
| Total Asset | 435.75 M | |||
| Retained Earnings | (885.34 M) | |||
| Current Asset | 112.03 M | |||
| Current Liabilities | 7.72 M | |||
About Ardelyx Performance
Evaluating Ardelyx's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Ardelyx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ardelyx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. Ardelyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 86 people.Things to note about Ardelyx performance evaluation
Checking the ongoing alerts about Ardelyx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ardelyx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ardelyx appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 333.62 M. Net Loss for the year was (39.14 M) with profit before overhead, payroll, taxes, and interest of 288.94 M. | |
| Ardelyx currently holds about 90.62 M in cash with (44.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Roughly 70.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Ardelyx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ardelyx's stock is overvalued or undervalued compared to its peers.
- Examining Ardelyx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ardelyx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ardelyx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ardelyx's stock. These opinions can provide insight into Ardelyx's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Ardelyx Stock Analysis
When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.